|
|
|
|
| Symbol(s): |
NYMX |
| Date: |
18-Apr-13 |
| Author: |
Hunter Orr |
| Contributor: |
Alpha Street Research |
| Title: |
NYMX - Nymox Pharmaceutical Corp - Downgraded to a Sell - Research Report by ASR |
| Document Size: |
9 pages |
| Price: |
$24 |
| Document Type: |
Adobe Acrobat Reader®
Download free Adobe Acrobat Reader® |
|
| Research Reports Premium Services |
| ·
|
Get the full report for $24. |
| ·
|
You will have access to this report for 24 hours. |
|
|
|
|
|
| www.AlphaStreetResearch.com - Full Coverage of 3,000 U.S. equities. Reports include Financials, Ratios, Competitor Comparison, and our proprietary ASR Ranking indicating Buy/Sell/Hold. Nymox Pharmaceutical Corporation is a biopharmaceutical company. The Company is engaged in therapeutics in development for enlarged prostate (BPH), E. coli, Alzheimer's disease and other indications and diagnostics for tobacco exposure, Alzheimer's disease and other conditions.
| | |
|
|
